The 5-FU Holter Study
ConditionGastrointestinal Malignancy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Auckland, New Zealand
About this trial
To assess the feasibility of using ambulatory ECG monitoring (Holter monitor) for patients receiving 5-FU chemotherapy
Eligibility criteria
Qualifiers
Patients with diagnosis of gastrointestinal malignancy
Planned to receive either FOLFOX chemotherapy with any treatment intent
Aged ≥ 18 years at time of signing informed consent form
Disqualifiers
None
Trial design
Treatments tested in this trial
- Holter monitor
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Auckland, New Zealand
Lead sponsor
Auckland City Hospital
Sponsor institution
Gut Cancer Foundation
Collaborator
Auckland City Hospital
Collaborator
The Heart Group
Collaborator
Source ClinicalTrials.gov